Online Database of Chemicals from Around the World
Search |  Submit |  中文
Home >> Chemical Listing >> A >> N-Acetyl-4-[5-(4-methylphenyl)-3-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide

N-Acetyl-4-[5-(4-methylphenyl)-3-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide
[CAS# 198471-47-5]

List of Suppliers
Shanghai Forever Synthesis Co.,Ltd. China Inquire  
+86 (551) 6288-8437
+86 18096409024
sales@foreversyn.com
sales02@foreversyn.com
Skype Chat
QQ chat
Chemical distributor since 2013
chemBlink standard supplier since 2018
Complete supplier list of N-Acetyl-4-[5-(4-methylphenyl)-3-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide
Identification
Name N-Acetyl-4-[5-(4-methylphenyl)-3-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide
Synonyms N-[[4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]sulfonyl]acetamide
Molecular Structure CAS # 198471-47-5, N-Acetyl-4-[5-(4-methylphenyl)-3-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide, N-[[4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]sulfonyl]acetamide
Molecular Formula C19H16F3N3O3S
Molecular Weight 423.41
CAS Registry Number 198471-47-5
Properties
Solubility Insoluble (3.0E-3 g/L) (25 ºC), Calc.*
Density 1.39±0.1 g/cm3 (20 ºC 760 Torr), Calc.*
Melting point 164-166 ºC**
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2019 ACD/Labs)
** Croitoru, Maria; Revista de Chimie (Bucharest, Romania) 2005, V56(2), P164-168.
Market Analysis Reports
List of Reports Available for N-Acetyl-4-[5-(4-methylphenyl)-3-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide
Related Products
O-(N-Acetyl-alpha-neuraminosyl)-(2→3)-O-[O-(N-acetyl-alpha-neuraminosyl)-(2→3)-O-beta-D-galactopyranosyl-(1→3)-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1→4)]-O-beta-D-galactopyranosyl-(1→4)-D-glucose  O-(N-Acetyl-alpha-neuraminosyl)-(2→6)-O-[O-6-deoxy-alpha-L-galactopyranosyl-(1→2)-beta-D-galactopyranosyl-(1→3)]-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→3)-O-beta-D-galactopyranosyl-(1→4)-D-glucose  O-(N-Acetyl-alpha-neuraminosyl)-(2→6)-O-beta-D-galactopyranosyl-(1→4)-2-(acetylamino)-2-deoxy-D-galactose  O-(N-Acetyl-alpha-neuraminosyl)-(2→6)-O-beta-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→2)-O-alpha-D-mannopyranosyl-(1→3)-O-[O-(N-acetyl-alpha-neuraminosyl)-(2→6)-O-beta-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→2)-alpha-D-mannopyranosyl-(1→6)]-O-beta-D-mannopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→4)-2-(acetylamino)-2-deoxy-D-glucose  (3aS,4S,6aR)-N-[6-[[3-[[O-(N-Acetyl-alpha-neuraminosyl)-(2→6)-O-beta-D-galactopyranosyl-(1→4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]oxy]propyl]amino]-6-oxohexyl]hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide  (3aS,4S,6aR)-N-[6-[[3-[[O-(N-Acetyl-alpha-neuraminosyl)-(2→3)-O-beta-D-galactopyranosyl-(1→3)-2-(acetylamino)-2-deoxy-D-glucopyranosyl]oxy]propyl]amino]-6-oxohexyl]hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide  (3aS,4S,6aR)-N-[6-[[3-[[O-(N-Acetyl-alpha-neuraminosyl)-(2→3)-O-alpha-D-galactopyranosyl-(1→3)-O-[6-deoxy-alpha-L-galactopyranosyl-(1→4)]-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]oxy]propyl]amino]-6-oxohexyl]hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide  [3aS-(3aalpha,4beta,6aalpha)]-N-[6-[[O-(N-Acetyl-alpha-neuraminosyl)-(2→3)-O-beta-D-galactopyranosyl-(1→4)-D-glucopyranosyl]amino]-6-oxohexyl]hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide  (2-Acetyl-4-methylpentyl)trimethylammonium iodide  2-Acetyl-6-methylphenol  1-Acetyl-N-methyl-4-piperidinamine monohydrochloride  3-acetyl-6-methyl-2H-Pyran-2,4(3H)-dione sodium salt monohydrate  2-Acetyl-3-methylpyrazine  3-Acetyl-5-methylpyrazole  3-Acetyl-2-methylpyridine  5-Acetyl-2-methylpyridine  2-Acetyl-6-methylpyridine  2-Acetyl-4-methylpyridine  5-Acetyl-6-methyl-3-pyridinecarbonitrile  4-Acetyl-6-methylpyrimidine